Healthcare provider profile · identity verified

Jonathan Wolkwitz, PA

Physician Assistant · DEXTER, NM · NPI 1831186303

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	228	50
Levothyroxine Sodium	Levothyroxine Sodium	203	38
Amlodipine Besylate	Amlodipine Besylate	200	49
Atorvastatin Calcium	Atorvastatin Calcium	194	53
Losartan Potassium	Losartan Potassium	182	44
Pantoprazole Sodium	Pantoprazole Sodium	145	38
Metformin Hcl	Metformin Hcl	143	36
Glipizide Er	Glipizide	125	28
Alprazolam	Alprazolam	122	17
Gabapentin	Gabapentin	121	23
Prednisone	Prednisone	119	59
Pioglitazone Hcl	Pioglitazone Hcl	114	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	112	14
Rosuvastatin Calcium	Rosuvastatin Calcium	112	28
Omeprazole	Omeprazole	101	24
Allopurinol	Allopurinol	99	20
Metformin Hcl Er	Metformin Hcl	99	20
Metoprolol Succinate	Metoprolol Succinate	96	25
Januvia	Sitagliptin Phosphate	95	22
Sertraline Hcl	Sertraline Hcl	95	26
Famotidine	Famotidine	92	17
Tamsulosin Hcl	Tamsulosin Hcl	92	21
Ezetimibe	Ezetimibe	88	21
Potassium Chloride	Potassium Chloride	88	15
Furosemide	Furosemide	86	19
Hydrochlorothiazide	Hydrochlorothiazide	81	19
Alendronate Sodium	Alendronate Sodium	77	17
Zolpidem Tartrate	Zolpidem Tartrate	70	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	16
Fenofibrate	Fenofibrate,micronized	66	18
Azelastine Hcl	Azelastine Hcl	62	11
Fluticasone Propionate	Fluticasone Propionate	62	16
Trulicity	Dulaglutide	61	suppressed
Trazodone Hcl	Trazodone Hcl	59	13
Meloxicam	Meloxicam	57	12
Fluoxetine Hcl	Fluoxetine Hcl	56	suppressed
Ibuprofen	Ibuprofen	55	14
Simvastatin	Simvastatin	54	12
Montelukast Sodium	Montelukast Sodium	53	11
Albuterol Sulfate Hfa	Albuterol Sulfate	52	18
Cefuroxime	Cefuroxime Axetil	51	35
Diclofenac Sodium	Diclofenac Sodium	50	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Lovastatin	Lovastatin	49	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	46	11
Atenolol	Atenolol	45	suppressed
Bumetanide	Bumetanide	45	11
Glipizide	Glipizide	42	suppressed
Pravastatin Sodium	Pravastatin Sodium	41	suppressed
Azithromycin	Azithromycin	39	32
Esomeprazole Magnesium	Esomeprazole Magnesium	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Naproxen	Naproxen	36	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	25
Clonidine Hcl	Clonidine Hcl	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	26
Gemfibrozil	Gemfibrozil	33	suppressed
Carvedilol	Carvedilol	32	11
Estradiol	Estradiol	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Rizatriptan	Rizatriptan Benzoate	27	suppressed
Temazepam	Temazepam	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	16
Desmopressin Acetate	Desmopressin Acetate	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Baclofen	Baclofen	24	17
Cephalexin	Cephalexin	23	16
Calcitonin-Salmon	Calcitonin,salmon,synthetic	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Amoxicillin	Amoxicillin	21	16
Diazepam	Diazepam	21	suppressed
Eliquis	Apixaban	21	suppressed
Levofloxacin	Levofloxacin	21	16
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Premarin	Estrogens, Conjugated	20	suppressed
Cefprozil	Cefprozil	18	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	12
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Lactulose	Lactulose	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Nystatin	Nystatin	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Primidone	Primidone	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Acarbose	Acarbose	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error